Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Nicole N.M. Blijlevens"'
Autor:
Anton F.J. de Haan, Marco R. de Groot, Nicole N.M. Blijlevens, Gerwin Huls, Andre B. Mulder, Marjan Cruijsen, Nicolaas Schaap, Joop H. Jansen, Edo Vellenga, B. Bär, Frédéric Baron, Walter J.F.M. van der Velden, Jacobien R. Hilberink
Publikováno v:
Bone Marrow Transplantation, 56, 8, pp. 1964-1970
Bone marrow transplantation, 56(8), 1964-1970. Nature Publishing Group
Bone Marrow Transplantation, 56, 1964-1970
Bone marrow transplantation, 56(8), 1964-1970. Nature Publishing Group
Bone Marrow Transplantation, 56, 1964-1970
Contains fulltext : 237746.pdf (Publisher’s version ) (Closed access) Patients with poor risk acute myeloid leukemia (AML) have a dismal outcome. We hypothesized that combining decitabine with a standard non-myeloablative (NMA) conditioning regimen
Autor:
D. Kalter, L.F.J. van Groningen, Nicole N.M. Blijlevens, Wim J. E. Tissing, W.J.F.M. van der Velden
Publikováno v:
HemaSphere. 3:1023
Autor:
Gerwin Huls, Nicole N.M. Blijlevens, Marjan Cruijsen, Nicolaas Schaap, Joop H. Jansen, Walter J.F.M. van der Velden, Michel G.D. Kester, Manita E J Bremmers, B. Bär, J.H. Frederik Falkenburg, Rob Woestenenk, Harry Dolstra, Willemijn Hobo
Publikováno v:
Biology of Blood and Marrow Transplantation, 22, 1000-1008
Biology of Blood and Marrow Transplantation, 22(6), 1000-1008
Biology of Blood and Marrow Transplantation, 22, 6, pp. 1000-1008
Biology of Blood and Marrow Transplantation, 22(6), 1000-1008
Biology of Blood and Marrow Transplantation, 22, 6, pp. 1000-1008
Allogeneic hematopoietic cell transplantation (HCT) offers the possibility of curative therapy for patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myelogenous leukemia (AML). However, post-HCT relapse